So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
All content for EnRitched Menopause is the property of Jessica Ritch, MD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
Ever felt sudden shoulder stiffness or pain that makes even lifting your arm a challenge? You might think it’s a pulled muscle or a rotator cuff issue — but for many women in their 40s to 60s, it could be something far more specific: frozen shoulder. In this episode, Dr. Jessica Ritch opens up about her own experience with shoulder pain that turned out to be frozen shoulder — a condition that disproportionately affects women in perimenopause and menopause. Together with returning guest Dr. Jo...
EnRitched Menopause
So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
